Pharming Group

Pharming Group: Building a sustainable rare disease business, preparing for approval/launch of leniolisib for APDS. Revenues >$200M (TTM) from Ruconest (marketed) for the treatment of acute hereditary angioedema (HAE) attacks including breakthrough attacks. Leniolisib, a targeted PI3Kδ inhibitor initially being developed for PI3K delta syndrome (APDS), is on track to be the first approved disease-modifying treatment for APDS, a rare genetic immunodeficiency. Regulatory approvals expected from the US FDA in Q1 2023 and EU EMA in H1 2023 under priority review/ accelerated assessment, with commercial launch expected in the US H1 and EU H2 2023. Ruconest cash flow funds leniolisib and broader pipeline development. Dual listed on Nasdaq.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Marketed, Registration Stage
Disease Space
Anti-inflammatory, Complement Mediated, Rare Disease
Finance
Profitable, Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
500MM - 1B
Therapeutic Modalities
pi3k, Recombinant DNA, Small Molecule, Targeted Therapy
Website:
Profiles:
Address:
Vondellaan 47
Leiden, Zuid-Holland 2332AA
Netherlands

Company Participants at Solebury 1x1 Management Access Event 2023

  • Anurag Relan, Chief Medical Officer
  • Jeroen Wakkerman, CFO
  • Sijmen de Vries, CEO

Top 10 Holders of Pharming Group NV

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Acadian Asset Management LLC 3.07 19,982,959 0.00 Stakes 9/1/22
Victory Capital Management, Inc. (Investment Management) 0.01 47,698 0.00 Funds 10/31/22
KLP Kapitalforvaltning AS 0.02 117,591 0.00 Funds 11/30/22
Zürcher Kantonalbank (Investment Management) 0.02 112,073 0.00 Funds 11/30/22
Link Fund Solutions (Luxembourg) SA 0.02 100,000 0.00 Funds 2/28/22
Castlebay Investment Partners LLP 0.02 100,000 0.00 Funds 11/30/22
BlackRock Investment Management (UK) Ltd. 0.01 81,094 0.00 Funds 6/30/22
BlackRock Advisors (UK) Ltd. 0.01 65,201 0.00 Funds 7/31/22
Lingohr & Partner Asset Management GmbH 0.01 56,165 0.00 Funds 1/31/22
GAM Investment Management (Switzerland) AG 0.01 55,132 0.00 Funds 11/30/22

Top 10 Holders of Pharming Group NV ADR RegS

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Cowen Prime Advisors LLC 0.03 16,700 0.24 13F 9/30/22
Morgan Stanley Smith Barney LLC 0.01 6,750 0.10 13F 9/30/22
Geode Capital Management LLC 0.00 2,093 0.03 Funds 11/30/22
UBS Securities LLC 0.00 1,534 0.02 13F 9/30/22
Wells Fargo Clearing Services LLC 0.00 0 0.00 13F 9/30/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.